David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.09% |
| 2 | Technology | 17.04% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTR
2276
DELISTED
Frontier Communications Corp.
FTR
| $1.6M | ﹤0.01% |
804,716
+746,242
| +1,276% | +$1.81M |
|
2277
United Bankshares
UBSI
$6.45B
| $1.59M | ﹤0.01% |
44,008
-9,726
| -18% | -$351K |
|
2278
CALL
SPS Commerce
SPSC
$3.03B
| $1.59M | ﹤0.01% |
30,000
| – | – |
|
|
BAS
2279
DELISTED
Basis Energy Services, Inc.
BAS
| $1.59M | ﹤0.01% |
417,428
+34,040
| +9% | +$166K |
|
|
PXD
2280
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.58M | ﹤0.01% |
10,400
-38,900
| -79% | -$5.49M |
|
2281
Marriott Vacations Worldwide
VAC
$3.95B
| $1.57M | ﹤0.01% |
16,799
-376,028
| -96% | -$33.8M |
|
2282
Mammoth Energy Services
TUSK
$153M
| $1.56M | ﹤0.01% |
93,945
-13,374
| -12% | -$286K |
|
2283
Diamondback Energy
FANG
$55.8B
| $1.56M | ﹤0.01% |
15,381
-36,367
| -70% | -$3.73M |
|
2284
WaFd
WAFD
$2.66B
| $1.55M | ﹤0.01% |
53,710
-13,439
| -20% | -$395K |
|
|
LX
2285
LexinFintech Holdings
LX
$196M
| $1.55M | ﹤0.01% |
+147,683
| New | +$1.5M |
|
2286
Luxfer Holdings
LXFR
$459M
| $1.55M | ﹤0.01% |
62,029
-28,653
| -32% | -$575K |
|
2287
SEACOR Marine Holdings
SMHI
$259M
| $1.55M | ﹤0.01% |
116,391
-1,320
| -1% | -$17.6K |
|
2288
Financial Institutions
FISI
$807M
| $1.54M | ﹤0.01% |
56,819
-8,341
| -13% | -$235K |
|
2289
PUT
Cardinal Health
CAH
$54.8B
| $1.54M | ﹤0.01% |
32,000
-35,000
| -52% | -$1.75M |
|
|
LION
2290
DELISTED
Fidelity Southern Corporation
LION
| $1.54M | ﹤0.01% |
56,140
-19,613
| -26% | -$584K |
|
|
CNR
2291
Core Natural Resources Inc
CNR
$4.9B
| $1.54M | ﹤0.01% |
44,887
+5,693
| +15% | +$199K |
|
|
WRK
2292
CALL
DELISTED
WestRock Company
WRK
| $1.53M | ﹤0.01% |
40,000
+29,000
| +264% | +$1.13M |
|
2293
Flowers Foods
FLO
$1.49B
| $1.53M | ﹤0.01% |
71,583
+60,037
| +520% | +$1.2M |
|
2294
Suncor Energy
SU
$76.5B
| $1.52M | ﹤0.01% |
46,983
-740,637
| -94% | -$24.1M |
|
|
MR
2295
DELISTED
Montage Resources Corporation Common Stock
MR
| $1.52M | ﹤0.01% |
101,291
+70,105
| +225% | +$1.12M |
|
2296
TTEC Holdings
TTEC
$69.5M
| $1.52M | ﹤0.01% |
41,988
+15,091
| +56% | +$510K |
|
|
RP
2297
DELISTED
RealPage, Inc.
RP
| $1.52M | ﹤0.01% |
25,042
-19,814
| -44% | -$1.14M |
|
2298
PUT
Howard Hughes
HHH
$3.95B
| $1.52M | ﹤0.01% |
14,476
+4,510
| +45% | +$467K |
|
2299
CALL
Nektar Therapeutics
NKTR
$2.54B
| $1.51M | ﹤0.01% |
3,000
-1,000
| -25% | -$593K |
|
|
VCRA
2300
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.51M | ﹤0.01% |
47,802
-99,664
| -68% | -$3.53M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.